...
search icon
clgn-img

Collplant Biotechnologies Ltd Share Price

CLGN
NAQ
$0.705
+$0.04
(6%)
1D
Industry: Biotechnology Sector: Health Care

Collplant Biotechnologies Ltd Analyst Forecast

Collplant Biotechnologies Ltd Share Price Chart

Collplant Biotechnologies Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.54M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
69.36K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.59 L
$4.98 H
$0.705

About Collplant Biotechnologies Ltd, Common Stock

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. more

Industry: BiotechnologySector: Health Care

Collplant Biotechnologies Ltd Stock Returns

Time FrameCLGNSectorS&P500
1-Week Return-58.57%0.14%0.86%
1-Month Return-55.83%-0.72%-0.47%
3-Month Return-64.89%3.7%1.34%
6-Month Return-77.62%19.92%8.86%
1-Year Return-81.95%7%14.32%
3-Year Return-94.22%16.96%67.75%
5-Year Return-97.25%34.22%77.15%
10-Year Return-95.77%145.99%279.46%

Collplant Biotechnologies Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.14M15.64M299.00K10.96M515.00K[{"date":"2020-12-31","value":39.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.91,"profit":true},{"date":"2023-12-31","value":70.07,"profit":true},{"date":"2024-12-31","value":3.29,"profit":true}]
Cost of Revenue3.46M2.00M1.48M3.09M2.66M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.98,"profit":true},{"date":"2022-12-31","value":42.68,"profit":true},{"date":"2023-12-31","value":89.44,"profit":true},{"date":"2024-12-31","value":77.01,"profit":true}]
Gross Profit2.68M13.64M(1.18M)7.87M(2.15M)[{"date":"2020-12-31","value":19.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-8.63,"profit":false},{"date":"2023-12-31","value":57.69,"profit":true},{"date":"2024-12-31","value":-15.75,"profit":false}]
Gross Margin43.65%87.18%(393.65%)71.78%(417.09%)[{"date":"2020-12-31","value":50.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-451.53,"profit":false},{"date":"2023-12-31","value":82.33,"profit":true},{"date":"2024-12-31","value":-478.41,"profit":false}]
Operating Expenses8.28M13.57M15.92M15.38M15.10M[{"date":"2020-12-31","value":52,"profit":true},{"date":"2021-12-31","value":85.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.6,"profit":true},{"date":"2024-12-31","value":94.87,"profit":true}]
Operating Income(5.60M)65.00K(17.10M)(7.51M)(17.25M)[{"date":"2020-12-31","value":-8613.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26303.08,"profit":false},{"date":"2023-12-31","value":-11556.92,"profit":false},{"date":"2024-12-31","value":-26540,"profit":false}]
Total Non-Operating Income/Expense(169.00K)354.00K344.00K997.00K1.36M[{"date":"2020-12-31","value":-12.4,"profit":false},{"date":"2021-12-31","value":25.97,"profit":true},{"date":"2022-12-31","value":25.24,"profit":true},{"date":"2023-12-31","value":73.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(5.77M)237.00K(16.93M)(7.02M)(16.61M)[{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2961.6,"profit":false},{"date":"2024-12-31","value":-7008.02,"profit":false}]
Income Taxes34.00K(172.00K)(172.00K)(1.00)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-505.88,"profit":false},{"date":"2022-12-31","value":-505.88,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(5.81M)409.00K(16.75M)(7.02M)-[{"date":"2020-12-31","value":-1420.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4096.09,"profit":false},{"date":"2023-12-31","value":-1716.14,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(5.77M)237.00K(16.93M)(6.73M)(16.61M)[{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2840.08,"profit":false},{"date":"2024-12-31","value":-7008.02,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(5.77M)237.00K(16.93M)(7.02M)(16.61M)[{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2961.6,"profit":false},{"date":"2024-12-31","value":-7008.02,"profit":false}]
EPS (Diluted)(0.79)(0.01)(1.53)(0.46)(1.45)[{"date":"2020-12-31","value":-79,"profit":false},{"date":"2021-12-31","value":-1,"profit":false},{"date":"2022-12-31","value":-153,"profit":false},{"date":"2023-12-31","value":-46,"profit":false},{"date":"2024-12-31","value":-145,"profit":false}]

Collplant Biotechnologies Ltd Ratios

Collplant Biotechnologies Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CLGN
Cash Ratio 3.25
Current Ratio 3.66
Quick Ratio 3.45

Collplant Biotechnologies Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLGN
ROA (LTM) -42.11%
ROE (LTM) -92.74%

Collplant Biotechnologies Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLGN
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.66

Collplant Biotechnologies Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLGN
Trailing PE NM
Forward PE 80.00
P/S (TTM) 3.64
P/B 0.89
Price/FCF NM
EV/R 1.07
EV/Ebitda NM

FAQs

What is Collplant Biotechnologies Ltd share price today?

Collplant Biotechnologies Ltd (CLGN) share price today is $0.705

Can Indians buy Collplant Biotechnologies Ltd shares?

Yes, Indians can buy shares of Collplant Biotechnologies Ltd (CLGN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Collplant Biotechnologies Ltd be purchased?

Yes, you can purchase fractional shares of Collplant Biotechnologies Ltd (CLGN) via the Vested app. You can start investing in Collplant Biotechnologies Ltd (CLGN) with a minimum investment of $1.

How to invest in Collplant Biotechnologies Ltd shares from India?

You can invest in shares of Collplant Biotechnologies Ltd (CLGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Collplant Biotechnologies Ltd shares
What is Collplant Biotechnologies Ltd 52-week high and low stock price?

The 52-week high price of Collplant Biotechnologies Ltd (CLGN) is $4.98. The 52-week low price of Collplant Biotechnologies Ltd (CLGN) is $0.59.

What is Collplant Biotechnologies Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Collplant Biotechnologies Ltd (CLGN) is

What is Collplant Biotechnologies Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Collplant Biotechnologies Ltd (CLGN) is 0.89

What is Collplant Biotechnologies Ltd dividend yield?

The dividend yield of Collplant Biotechnologies Ltd (CLGN) is 0.00%

What is the Market Cap of Collplant Biotechnologies Ltd?

The market capitalization of Collplant Biotechnologies Ltd (CLGN) is $8.54M

What is Collplant Biotechnologies Ltd's stock symbol?

The stock symbol (or ticker) of Collplant Biotechnologies Ltd is CLGN

How Can Investors Use Collplant Biotechnologies Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Collplant Biotechnologies Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Collplant Biotechnologies Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Collplant Biotechnologies Ltd shares for Indian investors?

When investing in Collplant Biotechnologies Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Collplant Biotechnologies Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Collplant Biotechnologies Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Collplant Biotechnologies Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Collplant Biotechnologies Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top